CTSZ and early-onset autosomal dominant Alzheimer disease: To date, cathepsin Z has been found to be involved in cancer models (22, 39, 40), rheumatoid arthritis (41), Alzheimer’s disease (42), Sjogren’s syndrome (43), and primary biliary cholangitis (44).